Replicel Life Sciences Stock Beta
| RP Stock | CAD 0.06 0.00 0.00% |
RepliCel Life Sciences fundamentals help investors to digest information that contributes to RepliCel Life's financial success or failures. It also enables traders to predict the movement of RepliCel Stock. The fundamental analysis module provides a way to measure RepliCel Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RepliCel Life stock.
RepliCel | Beta |
RepliCel Life Sciences Company Beta Analysis
RepliCel Life's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current RepliCel Life Beta | 0.79 |
Most of RepliCel Life's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RepliCel Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
RepliCel Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for RepliCel Life is extremely important. It helps to project a fair market value of RepliCel Stock properly, considering its historical fundamentals such as Beta. Since RepliCel Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of RepliCel Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of RepliCel Life's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, RepliCel Life Sciences has a Beta of 0.785. This is 8.72% lower than that of the Biotechnology sector and 43.53% lower than that of the Health Care industry. The beta for all Canada stocks is notably lower than that of the firm.
RepliCel Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of RepliCel Life from analyzing RepliCel Life's financial statements. These drivers represent accounts that assess RepliCel Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of RepliCel Life's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.1M | 6.2M | 7.5M | 3.2M | 3.7M | 3.5M | |
| Enterprise Value | 6.6M | 6.2M | 7.3M | 2.8M | 3.3M | 3.1M |
As returns on the market increase, RepliCel Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding RepliCel Life is expected to be smaller as well.
RepliCel Fundamentals
| Return On Asset | -2.33 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | (3.68) % | ||||
| Current Valuation | 4.35 M | ||||
| Shares Outstanding | 65 M | ||||
| Shares Owned By Insiders | 62.69 % | ||||
| Number Of Shares Shorted | 869 | ||||
| Price To Earning | (1.05) X | ||||
| Price To Sales | 10.11 X | ||||
| Revenue | 353.74 K | ||||
| Gross Profit | 353.74 K | ||||
| EBITDA | (1.47 M) | ||||
| Net Income | (69.29 K) | ||||
| Cash And Equivalents | 1.16 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 40.96 K | ||||
| Current Ratio | 2.09 X | ||||
| Book Value Per Share | (0.10) X | ||||
| Cash Flow From Operations | (1.99 M) | ||||
| Short Ratio | 0.13 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 1.64 | ||||
| Beta | 0.79 | ||||
| Market Capitalization | 3.58 M | ||||
| Total Asset | 798.22 K | ||||
| Retained Earnings | (42.97 M) | ||||
| Working Capital | (1.44 M) | ||||
| Net Asset | 798.22 K |
About RepliCel Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RepliCel Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RepliCel Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RepliCel Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for RepliCel Stock analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |